Commitments and Contingencies (Details Narrative) - USD ($)		1 Months Ended			12 Months Ended
	Dec. 29, 2023	Aug. 31, 2023	Aug. 31, 2022	Oct. 31, 2019	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jun. 24, 2024	May 31, 2024	Nov. 06, 2023	Nov. 15, 2022	Oct. 31, 2021	Jan. 31, 2019
Related Party Transaction [Line Items]
Accounts payable					$ 1,467,052	$ 680,325
Loss on legal settlement				$ 267,680
Repayments of notes payable						146,912
Repayments of related party debt						146,912
Settlement expense		$ 38,838
Loss contingency liability					$ 113,000
Common stock, shares			360,000
Warrants to purchase shares	180,000				247,500
Warrants exercise price	$ 0.75				$ 0.75
Subsequent Event [Member]
Related Party Transaction [Line Items]
Account accrued and unpaid interest									$ 117,000
Final payment resolved								$ 135,000
Court Officer [Member]
Related Party Transaction [Line Items]
Repayments of notes payable							$ 103,088
Promissory Note [Member]
Related Party Transaction [Line Items]
Notes payable, principal amount													$ 250,000
Sponsored Research Agreement [Member]
Related Party Transaction [Line Items]
Budget research expense										$ 1,296,000	$ 1,300,000	$ 1,300,000
Yeda Research and License Agreement [Member]
Related Party Transaction [Line Items]
Research and development expense					$ 58,000	58,000
Accrued liabilities current					72,500	14,500
MD Anderson Sponsored Research Agreements [Member]
Related Party Transaction [Line Items]
Research and development expense					1,406,193	1,823,525
Accrued liabilities current					0
Accounts payable					924,705
Settlement Agreement [Member]
Related Party Transaction [Line Items]
Loss on legal settlement					142,600
Common stock, shares	180,000
Warrants to purchase shares	180,000
Warrants exercise price	$ 0.75
Convertible promissory note	$ 50,000
Yeda [Member]
Related Party Transaction [Line Items]
Budget research expense					$ 0	$ 0